Abstract | Exposure to endocrine disrupting chemicals (EDCs) is associated with dysfunctions of metabolism, energy balance, thyroid function and reproduction, and an increased risk of endocrine cancers. These multifactorial disorders can be 'programmed' through molecular epigenetic changes induced by exposure to EDCs early in life, the expression of which may not manifest until adulthood. In some cases, EDCs have detrimental effects on subsequent generations, which indicates that traits for disease predisposition may be passed to future generations by nongenomic inheritance. This Review discusses current understanding of the epigenetic mechanisms that underlie sexual differentiation of reproductive neuroendocrine systems in mammals and summarizes the literature on transgenerational epigenetic effects of representative EDCs: vinclozolin, diethylstilbesterol, bisphenol A and polychlorinated biphenyls. The article differentiates between contextdependent epigenetic transgenerational changes-namely, those that require environmental exposure, either via the EDC itself or through behavioral or physiological differences in parents-and germline-dependent epigenetic mechanisms. These processes, albeit discrete, are not mutually exclusive and can involve similar molecular mechanisms including DNA methylation and histone modifications and may predispose exposed individuals to transgenerational disruption of reproductive processes. New insights stress the crucial need to develop a clear understanding of how EDCs may program the epigenome of exposed individuals and their descendants.
Introduction
Scientists, the general public, policy makers and the media have focused on the effect of environmental con taminants on human health and ecosystems. Deformities and reproductive anomalies in fish and amphibians have captured the headlines, as have reports on early puberty in young girls. Whether or not to ban bisphenol A (BPA), a compound used in the production of plastics and mater ials used as food containers, has been the subject of much debate by regulatory agencies throughout Europe and North America. All of these scena rios have some thing in common-they are attributed at least in part to environmental endocrine disrupting chemicals (EDCs).
EDCs are compounds that interfere with the ability of endocrine systems to maintain homeostasis (Box 1). 1, 2 These compounds have entered the environment from industrial waste, contaminated water systems, the wide spread use of chemical pest control products and many other sources. From the air, soil and water, EDCs enter the food chain. Because some of these compounds are lipophilic and persistent, they have the potential to bio accumulate and become a part of a plant's or animal's body burden. Concentrations of such EDCs can, there fore, biomagnify as they work their way up the food chain. Top predators, for example, eagles, seals, polar bears and humans, have amongst the highest concentrations of these bioaccumulative EDCs in their bodies.
In the USA, more than 80,000 chemicals are registered with the Environmental Protection Agency, some of which are known or potential EDCs. Although not all of these compounds are still in commercial use, it remains imperative that we act now to develop an under standing of how these compounds affect human and wildlife popula tions in both the short term and the long term. 3, 4 Endocrine systems maintain homeostasis through the release of hormones from glands that, in turn, are regu lated by feedback circuits. When perturbed, hormonal systems that control reproduction, stress, metabolism, energy balance, growth and electrolyte balance cannot function properly, and dysregulation and disease result. The timing of exposure is critically important in deter mining the effects of EDC exposures. Although no life stage is immune to EDC effects, the developing organ ism is particularly vulnerable. The concept of the 'fetal (develop mental) basis of adult disease' has been pro posed 5 to explain how the prenatal and early postnatal periods of development are highly sensitive to environ mental perturbations, including those related to exposure to EDCs. 6 Such exposures, even at very low levels, may 'reprogram' the developing organism through irrever sible changes in gene expression and predispose it for dys function much later in life.
Research in the past decade has provided compelling evidence for the biological plausibility of links between early life exposures to EDCs and an increased propen sity to develop adult endocrine disorders, including endocrine cancers, infertility, type 2 diabetes mellitus, obesity or thyroid disease, although considerable contro versy remains. Mechanistic molecular studies have begun to unravel how EDCs may act. Among the most exciting but disturbing discoveries is the finding that the effects of EDCs are not limited to an exposed individual but can be transmitted to future generations.
As will be discussed in this Review, effects of EDCs on the germline (sperm, ova) may reprogram molecu lar epigenetic processes such as DNA methylation and histone modifications, among others (Box 2). These developmental programming changes can, in some cases, be heritable via germline transmission to subsequent gen eration and, thereby, initiate a transgenerational cascade. The actions of EDCs on the brain, behavior and hormone concentrations or actions in exposed parents, especially the mother, might also change maternal behavior and in turn modify epigenetic programming of offspring in a germlineindependent manner, as elaborated upon below. Some animal and human populations are geo graphically constrained due to a variety of factors that may be beyond the individuals' control. For example, in humans, socio economic, job or family circumstances may limit geo graphic mobility. Wildlife might also be constrained owing to their social systems and avail ability (or lack) of a suitable habitat or resources. If people and animals reside in contaminated environments, such constraints may also cause many generations of offspring to have continued exposure to the contaminated environ ment. [7] [8] [9] In these situations, epigenetic alterations that cross generations are again germlineindependent, as they relate to the social or physical environment of the family or litter and have been referred to by David Crews as 'context dependent epigenetic modification or change' . 10 Understanding the molecular mechanisms involved in both germline dependent and contextdependent EDCrelated epi genetic reprogramming is more important than ever in order to enable humans to intervene now to break the cycle of transgenerational transmission.
Hypothalamic sexual differentiation
The central neuroendocrine systems control reproduc tive function through the release of the hypothalamic (gonadotropinreleasing hormone), pituitary (luteiniz ing hormone [LH] , folliclestimulating hormone) and gonadal steroid (estradiol, progesterone and testo sterone) hormones ( Figure 1 ). Reproductive neuro endocrine systems are sexually dimorphic and accommodate obvious sex differences in gametogenesis, steroidogenesis and sexual behavior. The control of these processes takes place in a common hypothalamic-limbic neural network that develops in a sexually dimorphic manner. This complex circuitry is organized in a sexspecific manner by gonadal steroid hormones during a critical period of development-usually late in fetal development and soon after birth in mammals-and results in the capacity for maletypical or femaletypical reproductive physiology and behavior in adulthood (Box 3). In reference to brain sexual differentiation, the term organization refers to developmental changes in the nervous system that must occur early in life to enable proper functioning later in life (for example, adulthood).
In males, circulating testosterone is important for masculiniza tion of reproductive organs but is also impor tant for the masculinization of the brain pri marily through its conversion to estradiol catalyzed by the aroma tase enzyme. 11, 12 Synthesis of the aromatase enzyme in the fetal brain 13 enables estradiol to act upon its neural estro gen receptors, ERα and ERβ, to cause masculinization. By contrast, the female brain has much lower exposure to testosterone or estradiol. In rodents, the female brain is further protected from maternal estrogens by circulating αfetoprotein in the fetus, 14 enabling the development of a femaletypical pattern of brain organization.
The consequences of the organizational effects of ster oids are beginning to be understood at the molecular level through studies in animal models. For example, gene and protein expression of steroid hormone receptors, neuro transmitters, and neuropeptides and their receptors in the hypothalamus differ considerably between males and females, even shortly after birth. Male and female brains are also morphologically and anatomically dif ferent. In rats, the sexually dimorphic nucleus of the preoptic area is larger in males than in females, 15, 16 and the antero ventral periventricular nucleus is larger in females than in males (Box 3). 17 These sexual dimorphisms are cor related with the ability of the adult organism to behave in a sextypical manner and to coordinate reproductive physiological processes with the social, physiological, nutritional and geographical environment.
Whereas the hypothalamus is organized early in life, activation of the sextypical physiology and behavior must occur before an organism attains adult reproduc tive competency. 18 This activational process typically occurs during puberty, when the developing adrenals and gonads begin to secrete increased levels of steroid hormones, particularly estrogens (estradiol), proges tins (progesterone) and androgens (testosterone and dihydro testosterone). The consequence of organization in early life, followed by activation in later life, is the ability of the organism to regulate reproductive physio logy and behavior in a manner that is appropriate to the sex of the animal and that enables it to respond to its environment in a manner that maximizes the likelihood of reproductive success.
The hypothalamic-pituitary-gonadal axis both pro duces and responds to reproductive hormones and is, therefore, vulnerable to EDCs that mimic or perturb hormonallysensitive pathways (Figure 1 ). Exposure to environmental EDCs, particularly during critical periods of development that include the organizational and activational periods, may interfere with normal neuroendocrine processes.
The remainder of this Review will discuss the epi genetic processes by which normal hypothalamic-pituitarygonadal function develops, consider the molecular mecha nisms by which EDCs may perturb these processes and review evidence for trans generational epigenetic trans mission of these disrupted traits to offspring. Considerable evidence shows that exposure to EDCs results in epi genetic changes both in vivo and in vitro; 19 however, our Figure 1 | The hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis of mammals is shown with hypothalamic-releasing factor neurons of the hypothalamus terminating in the median eminence above the anterior pituitary gland, where the portal capillary system communicates signals from the hypothalamus to the pituitary. The release of gonadotropinreleasing hormone from hypothalamic neurons specifically targets the anterior pituitary gonadotropes to synthesize and secrete luteinizing hormone and follicle-stimulating hormone. From there, these circulating gonadotropins act upon receptors in the gonad, ovary or testis, to activate gonadal steroidogenesis and gametogenesis. Steroid hormones in the circulation act upon peripheral targets and also feed back upon steroid-sensitive neurons in the brain and hypothalamus. Endocrine disrupting chemicals can disrupt HPG systems through interference with any or all of these pathways, particularly during developmental exposures. Shown in the figure is how endocrine disrupting chemicals may disrupt the hypothalamic level of the HPG axis through actions on neurons containing steroid hormone receptors. discussion will focus on four compounds for which not only epigenetic but also transgenerational effects have been evidenced in mammals in vivo: vinclozolin, diethyl stilbesterol, BPA and polyc hlorinated biphenyls (PCBs).
Epigenetics and the hypothalamus
Developmental programming of the hypothalamus in a sexually differentiated manner involves changes in the transcriptome or the regulatory machinery of mRNA transcription. 20 These processes involve epi genetic changes, which do not cause mutations to the DNA nucleo tide sequences but rather involve the ability of genes to be expressed or repressed through non genomic modifications. Epigenetic changes may be herit able by germline transmission or contextdependent inheritance. 10 Both of these processes, albeit indepen dent, can be accomplished by the same molecular epi genetic mecha nisms such as DNA methylation, histone modifi cations, chromatin remodeling and regulation via microRNAs.
DNA methylation is a modification of the DNA mol ecule in which a methyl group is covalently added to the cytosine of a CpG dinucleotide, which is a cytosine next to a guanine connected by a phosphodiester bond on a DNA strand ( Figure 2 ). In the regulatory regions of genes, CpG dinucleotides are sometimes found in clus ters called CpG islands. Generally, an increase of DNA methylation is associated with a decrease in gene expres sion, whereas a decrease in methylation is associated with an increase in gene expression. DNA methylation is a relatively stable event involved in longterm develop mental processes such as tissuespecific gene expression, gene imprinting and X chromosome inactivation. 21 Thus, DNA methylation is a plausible mechanism by which the hypothalamus is organized through sex steroid hor mones. 22, 23 Furthermore, DNA methylation of estrogen receptor α 24 and the progesterone receptor 22 are sexually dimorphic in the hypothalamus of neonatal rats, and female rats can be masculinized by neonatal treatment with estradiol.
Histone proteins aid in packaging the DNA into the nucleus and help regulate interactions of transcrip tion factors with the DNA (Figure 2 ). Modifications to histones include acetylation, phosphorylation, ubiquitina tion and methylation, which lead to a relaxed (transcriptionally active) or condensed (transcription ally repressed) chromatin state. For example, when histones are acetylated at lysines, a positive charge is removed from the histone tail, which leads to relaxation of the interaction between the DNA and the histone and increases the likelihood of transcription factor binding.
DNA methylation and histone modifications act in concert to regulate gene expression. When CpG sites are methylated, methylbinding proteins bind to the DNA molecule and recruit histone deacetylases, which remove acetyl groups from the tails of histones (usually H3 and H4). Certain histone modifications, such as an increase in acetylation, can lead to a remodeling of the chromatin such that it becomes fixed in an 'open state' , leading to a transcriptionally active gene via the recruitment of two Box 3 | Sexual differentiation and sexual dimorphisms of the hypothalamus The central nervous systems of developing male and female fetuses are remarkably similar in the early periods of gestation. During embryogenesis, exposures to hormones cause changes in neuronal phenotype, cell survival and the structure of brain regions in a sex-specific manner. The fetal male testis produces large quantities of testosterone, which is metabolized to estradiol through actions of the enzyme p450 aromatase. 11, 12 These hormonal exposures are necessary for normal brain masculinization. By contrast, the female ovary produces much lower levels of these gonadal steroid hormones. Additionally, in rodents, the female brain is further protected from maternal estrogens by the α-fetoprotein.
14 This phenomenon results in brain feminization.
The sexually dimorphic nucleus of the preoptic area (SDN-POA) was one of the first regions of the brain that was shown to be sexually dimorphic in structure. As first identified by Roger Gorski in rats, 82 the SDN-POA of males is approximately four time larger than in females. Its size is correlated with masculine sexual behavior. The anteroventral periventricular nucleus is another important sexually dimorphic nucleus in the preoptic area. 83 Its larger size and greater number of estrogen receptors in females are correlated with the ability of females, but not males, to respond to estradiol positive feedback and to cause the hypothalamic gonadotropin-releasing hormone neurons to drive ovulation.
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Figure 2 | DNA methylation and histone modifications. Two major epigenetic mechanisms, DNA methylation and histone modifications, act in concert to regulate gene transcription. The DNA double helix backbone is shown in blue. In DNA methylation, methyl groups are added to a cytosine that is immediately 5' to a guanine. In general, an increase in DNA methylation leads to a decrease in mRNA transcription. Histone modifications occur when functional groups are added to the tails of histones (histones shown in pink, with blue tails), leading to a 'relaxed' or 'condensed' chromatin state. Depending on the modification, the DNA will be more or less tightly wound around the histone thereby increasing or decreasing the likelihood of gene transcription. Adapted with permission from Macmillan Publishers Ltd © Qiu, J. Nature 441, 143-145 (2006). 79 REVIEWS enzymes (SWI/SNF) to the nucleosome. 21 Evidence from the past few years in rodents suggests that histone modi fications are sexually dimorphic in several brain regions 25 and, specifically, have a role in the masculinization of the bed nucleus of the stria terminalis, a region of the hypothalamus that is larger in males than in females. Treatment of neonatal males and andro genized female mice with the histone deacetylase inhibitor val proic acid resulted in a feminized bed nucleus of the stria termi nalis in adulthood. 26 Taken together, these data suggest that histone modifications may play an important part in sexual differentiation of the brain.
Contextdependent epigenetic mechanisms are mol ecular changes that require the exposure of the organism to a behavioral, hormonal or social context or the pres ence of a causative agent (such as an EDC); for the trait to be perpetuated the exposure must occur in each genera tion (Figure 3) . 10 For example, variations in maternal behavior and/or maternal stress in rodents program the developing fetal brain through alterations in epigenetic regulation of the hippocampal glucocorticoid receptor. Female offspring whose brains have been reprogrammed go on to exhibit the same types of maternal behaviors and to, thereby, reprogram their own offspring. 27 These processes are not mediated by classical Mendelian inheri tance, nor are they passed via the germline, as the epi genetic trait is also passed on to crossfostered offspring. Rather, the context of the animal's environment-its mother's hormones and behavior-caused the repro gramming. This example illustrates the point that both germline and contextdependent epigenetic modifi cations can be transmitted to further generations, but these processes differ in the sense that germline traits will 'breed true' , whereas contextdependent traits require the continued exposure of each individual to the environ mental stimulus. Contextdependent transgenerational epigenetic effects have also been investigated in relation to altered reproductive strategies in female rats 28 and the transmission of polycystic ovary syndrome. 29 
EDCs and epigenetic transmission
Accumulating evidence shows that the epigenetic effects of EDCs on DNA methylation in the germline result in transgenerational inheritance. During mammalian development, a wave of demethylation and subsequent remethylation of the germ cells occurs-a time when alterations to the epigenome are most likely to result in germline transmission (Figure 4) . 30 Very early in embry onic development, before sex determination, the germ cells migrate down the genital ridge to the bipotential and undifferentiated gonad. Once in the genital ridge, the DNA in the germ cells is demethylated. At the onset of sex determination, the germ cell DNA is remethylated in a sexspecific manner. Imprinted genes are those that are not demethylated during this time and retain the methy lation pattern of their maternal or paternal genome, which results in monoallelic expression of the imprinted gene. Germ cells undergo vast changes in methylation patterns during early development, which is why DNA methylation has been the focus of many investi gations and has been proposed as a major mechanism for transgenerational epigenetic effects. 31 The mechanisms by which steroid hormones are involved in sexual differentiation of the brain and body are due in part to their actions as transcription factors that modulate expression of target genes during those critical developmental periods when methylation status is being established. EDCs act on sexsteroid hormone receptors; therefore, developmental exposures to EDCs in parents may interfere with remethylation of the DNA in their germ cells and lead to altered programming of the genome in subsequent generations. The following sections will review the current literature on epi genetic mechanisms and the transgenerational effects of develop mental EDC exposures. This concept requires an appreci ation that exposure of a pregnant female (F0 genera tion) will directly expose her fetuses (F1 genera tion) and the germ cells of the fetuses that will later develop into the F2 generation. Thus, the first truly un exposed generation is the F3 generation (Table 1; Figure 5 ). Only a limited number of studies have investigated the molecular mecha nisms underlying the transgenerational effects of EDCs, thus, we speculate, when possible, upon the mechanisms that may underlie the transgenerational effects described below.
Vinclozolin
Transgenerational epigenetic effects of the anti androgenic EDC vinclozolin may be the most comprehensively studied to date (Table 1) . Vinclozolin is a dicarboximide fungicide widely used in agriculture, most widely in the viniculture industry. As with many EDCs, embryonic exposure to vinclozolin has longterm consequences on reproductive behavior and physio logy in the F1 gen eration of rats and mice. 32 In the past 5 years, studies focusing on the transgenerational effects of embryonic EDC effects can be passed from one generation to another through actions on genes and proteins that control hormone levels, neurobiological physiological functions, and behaviors, particularly maternal behaviors towards the offspring. As depicted here, prenatal exposure to an EDC in a dam can alter the hypothalamic control of her hormone levels and her behaviors towards her F1 pups. The F2 generation may exhibit differences in their own hormones and behavior due to the context of what they were exposed to during postnatal development from their F1 mother. Abbreviation: EDC, endocrine disrupting chemical.
exposure to vinclozolin and the epigenetic mechanisms underlying these alterations have been conducted. Michael Skinner's laboratory was the first to report epigenetic, transgenerational effects of vinclozolin in the rat, 33 and this model has recently been extended to the mouse. 34 Skinner and colleagues found that embry onic exposure of F1 fetuses to a high dose of vinclozo lin (100 mg/kg) from embryonic days 8-14 increased apoptosis of germ cells in the testes and decreased sperm motility and concentration in adulthood, an effect that was carried forward for at least four generations (F4) in male rats. These physiological effects were accompanied by alterations in DNA methylation in the testes of young (postnatal day 6) F1 males and the sperm of F2 and F3 adults, 33 which suggests that epigenetic mechanisms may underlie the reduced fertility phenotype.
Followup studies from the same laboratory confirmed and extended these initial findings. [35] [36] [37] Altered blood chemistry, an increase in kidney, testis and immune diseases and increased tumor incidence were observed in four generations (F1-F4) of males descended from the original fetallyexposed F1 male rats. 38 In females, increased uterine hemorrhage and anemia during preg nancy, glomerular abnormalities, altered blood chemistry and an increase in tumor incidence in three generations (F1-F3) were reported. 39 Microarray analysis of testes from male F1-F3 fetuses at embryonic day 16 has identi fied 196 genes affected by the original exposure, the majority of which were downregulated. Interestingly, expression of several genes involved in the regulation of DNA methylation, including DNA methyltransferases, was decreased in all three generations. 36 In mice, Stouder and PaoloGiacobino showed that vinclozolin (50 mg/kg exposure on embryonic days 10-18) decreased sperm motility in two genera tions of male mice but motility recovered to the level of controls by the third generation (F1 = 56%, F2 = 90%, F3 = 100%). 34 An increase in methylation of paternally imprinted genes and decreased methylation of maternally imprinted genes in the sperm of the F1 and F2 males was also observed, although most of the methylation patterns on imprinted genes had returned to the level of control animals by the F3 generation. 34 Environmental conditions may be integral to the induction of the trans generational epigenetic effects, as these findings were not replicated in two other laboratories (Table 1) , 40 ,41 possibly due to experimental differences. 42 Do the transgenerational epigenetic effects of vin clozolin have an evolutionary context? When tested for mate preference, female F3 descendents of vinclozolin exposed or vehicleexposed rats spent significantly more time with the F3 vehiclelineage male than the F3 vinclozolinlineage males ( Figure 6 ; Table 1 ). 7 Importantly, the males in this experiment were young and healthy and had not yet developed the reduced fer tility and disease phenotype. Thus, we postulate that females were discriminating against these males on the basis of something other than a decrease in fertility, such as pheromones, major histocompatibility proteins, vocalizations or behavioral differences. Interestingly, males showed no preference between untreated or treated females, 7 which is consistent with the well known concept in evolutionary biology and mate choice theory that the parent with the greatest investment (the female rat) has a stronger need to discriminate more carefully when choosing a partner.
The findings of Crews et al. 7 are also important because they showed, for the first time, that the trans generational effects of vinclozolin are manifested as reproductive behavioral changes. Since that report, F3 vinclozolinlineage male and female rats were also found to differ from corresponding F3 vehicle descendants in anxietylike behaviors and in gene expression in the hippo campus and amygdala, 43 brain regions involved in Taken together, these data suggest that perinatal expo sure to vinclozolin may alter the hypothalamo limbic system in subsequent generations of rats, providing a mechanistic basis for the behavioral alterations. Current work is underway to investigate expression of genes, and epigenetic markers in the hypothalamus of these rats. Also important for the field is the future study of more environ mentally relevant doses of vinclozolin for their potential epigenetic transgenerational actions. and Dmnt3a (PND 30) 59 Epididymis: Expression of Dnmt 1, 3a and 3b 58 Tumors, proliferative lesions of the testis (F2 males) 51 Fertility unaltered (F2 males and females) 51, 52 Serum E 2 (F2 males) 51 Uterine adenocarcinomas (F2 females) 52 Tumors of reproductive system (F2 females) 53 Rats Uterus: Total histone tri-methylation of K27 (PND 12) 60 Phosphorylation of histone methyltransferase EZH2 (PND 12) 60 Expression of CaBP-9k and Dio2; Gdf10, Car8, Gria2 and Mmp3 (5 months and PND 12)
-
Humans -
Birth defects (grandsons and daughters) 47 Risk for heart conditions (granddaughters) 47 Number of live births and altered menstrual cycles (daughters) 48 Small cell carcinoma of the ovary (granddaughter); 50 hypospadias (grandsons) 49 
Bisphenol A (BPA)
Mice Altered CpG methylation in the forebrain (embryo) 67 Shifts agouti coat color by decreasing DNA methylation 68 Maternal behavior altered with treatment in both F0 and F1 mothers 70 Rats Prostate: Methylation of several genes (PND 10 and 90); 66 methylation promoter region and mRNA expression of PDE4D3 66 Protein expression in testes:
AR, ERβ, SRC-1 and NCor in F1-F3 (adult); 64, 65 ERα in F1, p/CIP in F2, GRIP-1 in F2 and F3 (adult) 64, 65 Prostate intraepithelia neoplasia and cell proliferation (PND 200) 66 Fertility F1-F3 males (PND 75) 64 Body weight in F2 and F3 males (PDN 125) 64 
Polychlorinated biphenyls (PCBs)
Rats
Dnmt1 expression in hypothalamus and liver (PND 21) 75, 76 Dnmt1, 3a and 3b and methylation of 16 genes in the liver (PND 21) 76 Skews sex ratio towards females F1 and F2 (slightly) 74 LH and P 4 on proestrus and uterine weight in F2 (adult females) 74 = increase, = decrease and = no changes or no effect. Abbreviations: AR, androgen receptor; CaBP-9k, calbindin D9k; Car8, carbonic anhydrase related protein 8; Dio2, diodinase type 2; Dmnt, DNA methyltransferase; E, embryonic day; E 2 , estradiol; Ehmt1, histone methyltransferase; ER, estrogen receptor; EZH2, enhancer of zeste homolog 2; Gdf10, growth differentiation factor 10; Gria2, glutamate receptor, ionotropic, AMPA 2; GRIP-1, glutamate receptor interacting protein 1; K27, lysine 27; LH, luteinizing hormone; LPLase, lysophospholipase; Mmp3, matrix metalloproteinase 3; NCor, nuclear receptor co-repressor; P 4 , progesterone; p/CIP , cointegrator-associated protein; PDE4D3, phosphodiesterase type 4 variant 4; Peg, paternally expressed gene; PND, postnatal day; Snrpn, small nuclear ribonucleoprotein polypeptide N; SRC-1, steroid receptor coactivator 1.
Diethylstilbesterol
Transgenerational epigenetic effects of the estrogenic EDC diethylstilbesterol (DES) began with observations of rare vaginal clearcell carcinomas and reproductive tract abnormalities in young women whose mothers had been prescribed DES in a misguided effort to avert miscarriage (Table 1 ). These observations provided the first evidence for developmental programming or the fetal basis of adult disease caused by exogenous estrogens in humans. 44 A potent estrogenic pharmaceutical, DES not only failed to reduce miscarriage risk, but it also exposed the develop ing daughters and sons to high levels of prenatal estrogens and predisposed them to adult diseases. 45 Animal studies have replicated many of these effects of prenatal DES treatment and have begun to reveal the molecular mecha nisms by which DES programs develop ing tissues. 46 The case of DES is important because it is one of the first to link fetal exposure to a hormonally active compound with the latent development of disease years or even decades after the insult. This example in humans has laid the groundwork for much of the work on the effect of other EDC exposures to the fetus.
Epidemiological studies have also found that DES is associated with a small but significant increase in birth defects in grandchildren of women given DES during pregnancy. The granddaughters reported an increase in heart conditions, 47 slight but significant differences in their menstrual cycles and a reduction in live births when compared with women whose grandmothers were not exposed to DES. 48 Another study found an increase in the risk of hypospadias in the sons of women who were exposed to DES in utero, 49 and there was the single clinical observation that the 15yearold grand daughter of a woman who took DES while she was pregnant devel oped a smallcell carcinoma of the ovary. 50 Although the sample sizes in the last two studies were exceedingly small (28 and 1, respectively), they provide preliminary evidence for the potential of transgenerational effects of EDCs in the human population.
Rodent studies have revealed trans generational epi genetic effects of DES (Table 1) . DES exposure of the F1 generation during embryonic and early postnatal develop ment at a range of dosages had adverse consequences in the F2 generations. In F2 males, the incidence of pro liferative lesions of the testes was increased, and serum estradiol concentration was reduced. 51 In F2 females, the incidence of uterine aden ocarcinomas 52 and other tumors of the reproductive tract was increased in a subset of the dosage groups. 53 Exposure of newborn (postnatal day 1-5) F1 female mice to 2 μg of DES led to demethylation of the estrogensensitive gene lacto transferrin promoter at two CpG dinucleotides (-464 and -454) in the uterus, 54 and to upregulation of uterine expression of lactotransferrin in both F1 female mice and their F2 female offspring. 55 Female F1 animals exposed to the same dosing paradigm had decreased methylation of exon 4 of the Fos gene on postnatal day 5 and increased Fos mRNA expression in the uterus in adulthood. 56 Additionally, mice exposed gestationally to 10 μg/kg of DES from embryonic days 9-16 resulted in increased methylation of the homeobox A10 promoter and intron and increased HoxA10 protein expression in the postnatal uterus (day 14). 57 Treatment of newborn, female and male mice on post natal days 1-5 with 3 μg per pup per day of DES changed total DNA methylation in reproductive tissues. 58, 59 DES also altered expression of the enzymes that regulate DNA methylation (Table 1) . For example, expression of DNA methyltransferases 1, 3a and 3b was increased in the epididymis, and DNA methyl transferases 1 and 3b were increased in the uterus of mice exposed to DES compared with animals exposed to the vehicle control. 58, 59 Finally, in rats treated with 1 mg/kg DES on postnatal days 10-12, the exposure decreased global histone trimethylation at lysine 27 in the uterus on postnatal day 12 60 and altered the expression of several estrogensensitive genes in the uterus of the neonatal and adult exposed animals. 61 Although most of these studies have only been conducted in tissues from F1 individuals, they provide insight into the potential targets for molecular epigenetic modifica tions that merit further study in subsequent generations in rodents.
Bisphenol A BPA is a monomer used in the plastics industry that has estrogenic properties and has also been proposed to have effects on androgen and thyroid systems (Box 4). 62 Although extensively studied as an endocrine disruptor in the F1 generation in rodents (Table 1) , 63 only a few studies have focused on its effects in multiple genera tions. Salian et al. found that fertility was compromised in three generations of male rats when the pregnant or lactating dam was exposed to 1.2 or 2.4 μg/kg of BPA per day from gestational day 12 until postnatal day 21. Furthermore, immunohistochemisty revealed that androgen receptor, ERβ, 64 steroid receptor co regulator 1 and nuclear corepressor protein expression 65 were decreased in the testes of three generations of these rats (F1-F3). Interestingly, steroid receptor coregulators are also histone acetyl transferases and histone deacetylases. 21 These results suggest that early life exposure to BPA or other steroid receptor mimics may result in longterm alterations to histone modifications and chromatin remodeling in a transgenerational manner.
Early life exposure to BPA can cause longterm epi genetic changes. For example, BPA decreased DNA methylation of phosphodiesterase type 4 variant 4, an enzyme involved in the breakdown of cyclic AMP, in the prostate of rats, 66 altered DNA methylation in the fore brain of mice 67 and shifted coat color by decreasing DNA methylation of the agouti gene in viable, yellow, agouti A vy mice. 68 The agouti gene in mice encodes a gene involved in coat coloration, with color ranging from yellow to black depending upon the level of DNA methylation, and thus enables a visual determination of epigenetic modifi cations. 69 Finally, exposure to 10 μg/kg BPA on embryonic days 14-18 resulted in altered maternal behavior, as F0 and F1 dams spent less time nursing and more time away from their pups. 70 As mentioned above, differences in maternal behavior are transferred to subsequent genera tions via a contextdependent epigenetic mechanism in rats. 27, 28 Although more research is necessary, these data provide supportive evidence that maternal behavior may be regulated by an epi genetic mechanism in mice and that EDCs can disrupt this behavioral parameter. They also raise the provocative possibility for the inter actions of contextdependent and germlinedependent epi genetic modifications in a highly complex manner. 20 
Polychlorinated biphenyls
PCBs are persistent contaminants used in a variety of industrial applications as lubricants, in carbonless paper, in electric transformers, and for many other purposes, from the 1930s until the 1970s, at which time they were banned because of their carcinogenic properties. Depending upon their structures, PCBs can interact with various receptor and enzyme systems in the body including thyroid, reproductive, and neurotransmitter systems (Table 1) .
Prenatal PCB exposure has detrimental physio logical and behavioral effects on neuroendocrine systems of F1 female rats. [71] [72] [73] [74] Effects have also been reported in the F2 generation, and effects in F3 males and females are in the process of being studied. In F2 females whose grand mothers were injected during pregnancy (gesta tional days 16 and 18) with 0.1, 1 or 10 mg/kg of a mixture of PCBs, the LH preovulatory surge was attenu ated. 74 Additionally, these animals had lower serum pro gesterone concentrations on proestrus at the antici pated time of the pre ovulatory gonadotropinreleasing hormone/LH surge, slightly lower uterine weights, 74 and preliminary data suggest that androgen receptor mRNA expression is reduced in the preoptic area of F2 males and females on postnatal day 1. 6 Specific epi genetic effects were not investigated; however, other reports have shown that early life exposures to PCBs alter expression of DNA methyltransferases 1 in the hypo thalamus 75 and DNA methyl transferases 1, 3a and 3b in the liver. 75, 76 The doses of PCBs used in the studies described above were chosen to estimate levels in human body burden and are probably ecologically relevant. Together, these findings show that PCBs interfere with DNA methyla tion machin ery in the rat. Finally, numerous studies have shown that PCBs can have longterm effects on gene expression after developmental exposure, 77, 78 providing evidence that epi genetic mechanisms may be involved in the persistent effects of perinatal PCB exposure.
Conclusions
The study of EDCs has yielded new information regard ing the importance of the perinatal environment to longterm outcomes of disease states and human health. Research in the past decade has begun to illuminate the potential molecular mechanisms underlying the Box 4 | The controversy over bisphenol A There is considerable dispute in the scientific community about the endocrine disrupting properties of bisphenol A (BPA), a synthetic monomer that is used in the plastics industry. Originally synthesized in the 1930s, BPA is used in the production of plastics. When it was discovered that the presence of BPA caused estrogen-dependent cells to proliferate and for oocytes in mice exposed to BPA to have aneuploidy, endocrinologists began to investigate the endocrinedisrupting properties of BPA. 63 Very low-dose detrimental effects of BPA were reported on endocrine organs, including prostate, mammary gland, reproductive tract and neuroendocrine tissues. 3 These data continue to be challenged; 84 nevertheless, the weight of evidence supports a need to be concerned about low-dose BPA exposures 85 and to invoke the precautionary principle when new chemicals are introduced into household and food products.
programming of the epigenome, both during normal development as well as when it is disrupted. We are only beginning to understand how acute exposure to EDCs may result in longterm epigenetic effects on the develop ing individual and on subsequent generations through germlinedependent or contextdependent mechanisms of transmission. Although more research is necessary to fully understand the mechanisms and processes involved, policymakers and regulators must be pro active in preventing future exposures from environ mental EDCs. This action is imperative if we are to break the cycle of transgenerational transmission. Furthermore, by identify ing the molecular epigenetic mechanisms of transmission, we may be able to reverse adverse changes in DNA methylation and histone modifications through interventions targeted to these biological pathways.
Review criteria
We selected the articles for this Review by focusing on the four main endocrine disruptors (vinclozolin, diethylstilbestrol, bisphenol A and polychlorinated biphenyls) for which there is substantial evidence of both epigenetic and transgenerational effects on the reproductive system. Because the number of primary literature publications on this topic is limited, we did not have any other parameters for exclusion. We found most of the literature cited by searching PubMed and using the search terms "epigenetics" and "transgenerational." Additionally, we used a few review articles to help us cross-reference our citations and confirm that we had uncovered the complete body of literature on this topic. Although we initially identified some articles through their abstracts, we read all of the primary literature and review articles in order to compile as complete an understanding as possible on this topic.
